BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cavalli E, Petralia MC, Basile MS, Bramanti A, Bramanti P, Nicoletti F, Spandidos DA, Shoenfeld Y, Fagone P. Transcriptomic analysis of COVID‑19 lungs and bronchoalveolar lavage fluid samples reveals predominant B cell activation responses to infection. Int J Mol Med 2020;46:1266-73. [PMID: 32945352 DOI: 10.3892/ijmm.2020.4702] [Cited by in Crossref: 7] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Pang Z, Zhou G, Chong J, Xia J. Comprehensive Meta-Analysis of COVID-19 Global Metabolomics Datasets. Metabolites 2021;11:44. [PMID: 33435351 DOI: 10.3390/metabo11010044] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 10.0] [Reference Citation Analysis]
2 Peddapalli A, Gehani M, Kalle AM, Peddapalli SR, Peter AE, Sharad S. Demystifying Excess Immune Response in COVID-19 to Reposition an Orphan Drug for Down-Regulation of NF-κB: A Systematic Review. Viruses 2021;13:378. [PMID: 33673529 DOI: 10.3390/v13030378] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
3 Yang J, Yan Y, Zhong W. Application of omics technology to combat the COVID-19 pandemic. MedComm (2020) 2021;2:381-401. [PMID: 34766152 DOI: 10.1002/mco2.90] [Reference Citation Analysis]
4 Yarmohammadi A, Yarmohammadi M, Fakhri S, Khan H. Targeting pivotal inflammatory pathways in COVID-19: A mechanistic review. Eur J Pharmacol 2021;890:173620. [PMID: 33038418 DOI: 10.1016/j.ejphar.2020.173620] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
5 Muhammad JS, Saheb Sharif-Askari N, Cui ZG, Hamad M, Halwani R. SARS-CoV-2 Infection-Induced Promoter Hypomethylation as an Epigenetic Modulator of Heat Shock Protein A1L (HSPA1L) Gene. Front Genet 2021;12:622271. [PMID: 33679887 DOI: 10.3389/fgene.2021.622271] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 Kim DM, Seo JW, Kim Y, Park U, Ha NY, Park H, Yun NR, Kim DY, Yoon SH, Na YS, Moon DS, Lim SC, Kim CM, Kim YS, Cho NH. Eosinophil-mediated lung inflammation associated with elevated natural killer T cell response in COVID-19 patients. Korean J Intern Med 2021. [PMID: 34565131 DOI: 10.3904/kjim.2021.093] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Kim DM, Seo JW, Kim Y, Park U, Ha NY, Park H, Yun NR, Kim DY, Yoon SH, Na YS, Moon DS, Lim SC, Kim CM, Kim YS, Cho NH. Eosinophil-mediated lung inflammation associated with elevated natural killer T cell response in COVID-19 patients. Korean J Intern Med 2022;37:201-9. [PMID: 34565131 DOI: 10.3904/kjim.2021.093] [Reference Citation Analysis]
8 Li Y, Duche A, Sayer MR, Roosan D, Khalafalla FG, Ostrom RS, Totonchy J, Roosan MR. SARS-CoV-2 early infection signature identified potential key infection mechanisms and drug targets. BMC Genomics 2021;22:125. [PMID: 33602138 DOI: 10.1186/s12864-021-07433-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
9 Vázquez-Jiménez A, Avila-Ponce De León UE, Matadamas-Guzman M, Muciño-Olmos EA, Martínez-López YE, Escobedo-Tapia T, Resendis-Antonio O. On Deep Landscape Exploration of COVID-19 Patients Cells and Severity Markers. Front Immunol 2021;12:705646. [PMID: 34603282 DOI: 10.3389/fimmu.2021.705646] [Reference Citation Analysis]
10 Jain R, Ramaswamy S, Harilal D, Uddin M, Loney T, Nowotny N, Alsuwaidi H, Varghese R, Deesi Z, Alkhajeh A, Khansaheb H, Alsheikh-Ali A, Abou Tayoun A. Host transcriptomic profiling of COVID-19 patients with mild, moderate, and severe clinical outcomes. Comput Struct Biotechnol J 2021;19:153-60. [PMID: 33425248 DOI: 10.1016/j.csbj.2020.12.016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
11 Ligotti ME, Pojero F, Accardi G, Aiello A, Caruso C, Duro G, Candore G. Immunopathology and Immunosenescence, the Immunological Key Words of Severe COVID-19. Is There a Role for Stem Cell Transplantation? Front Cell Dev Biol 2021;9:725606. [PMID: 34595175 DOI: 10.3389/fcell.2021.725606] [Reference Citation Analysis]
12 Starshinova A, Malkova A, Zinchenko U, Kudlay D, Glushkova A, Dovgalyk I, Yablonskiy P, Shoenfeld Y. Efficacy of Different Types of Therapy for COVID-19: A Comprehensive Review. Life (Basel) 2021;11:753. [PMID: 34440497 DOI: 10.3390/life11080753] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Shahbazi M, Jafari M, Moulana Z, Sepidarkish M, Bagherzadeh M, Rezanejad M, Mirzakhani M, Javanian M, Bayani M, Sadeghi-Haddad-Zavareh M, Mehdinezhad H, Ghadimi R, Ghasemzadeh M, Shokuhi Rad A, Mohammadnia-Afrouzi M. Reduced frequency of T helper 17 and T helper 1 cells and their association with critical coronavirus disease 2019. APMIS 2021;129:271-9. [PMID: 33792109 DOI: 10.1111/apm.13129] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Karami H, Derakhshani A, Ghasemigol M, Fereidouni M, Miri-Moghaddam E, Baradaran B, Tabrizi NJ, Najafi S, Solimando AG, Marsh LM, Silvestris N, De Summa S, Paradiso AV, Racanelli V, Safarpour H. Weighted Gene Co-Expression Network Analysis Combined with Machine Learning Validation to Identify Key Modules and Hub Genes Associated with SARS-CoV-2 Infection. J Clin Med 2021;10:3567. [PMID: 34441862 DOI: 10.3390/jcm10163567] [Reference Citation Analysis]
15 Islam T, Rahman MR, Aydin B, Beklen H, Arga KY, Shahjaman M. Integrative transcriptomics analysis of lung epithelial cells and identification of repurposable drug candidates for COVID-19. Eur J Pharmacol 2020;887:173594. [PMID: 32971089 DOI: 10.1016/j.ejphar.2020.173594] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
16 Dragomanova S, Miteva S, Nicoletti F, Mangano K, Fagone P, Pricoco S, Staykov H, Tancheva L. Therapeutic Potential of Alpha-Lipoic Acid in Viral Infections, including COVID-19. Antioxidants (Basel) 2021;10:1294. [PMID: 34439542 DOI: 10.3390/antiox10081294] [Reference Citation Analysis]
17 Tancheva L, Petralia MC, Miteva S, Dragomanova S, Solak A, Kalfin R, Lazarova M, Yarkov D, Ciurleo R, Cavalli E, Bramanti A, Nicoletti F. Emerging Neurological and Psychobiological Aspects of COVID-19 Infection. Brain Sci 2020;10:E852. [PMID: 33198412 DOI: 10.3390/brainsci10110852] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
18 Megyeri K, Dernovics Á, Al-Luhaibi ZII, Rosztóczy A. COVID-19-associated diarrhea. World J Gastroenterol 2021; 27(23): 3208-3222 [PMID: 34163106 DOI: 10.3748/wjg.v27.i23.3208] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 6] [Article Influence: 11.0] [Reference Citation Analysis]
19 Zhang C, Feng YG, Tam C, Wang N, Feng Y. Transcriptional Profiling and Machine Learning Unveil a Concordant Biosignature of Type I Interferon-Inducible Host Response Across Nasal Swab and Pulmonary Tissue for COVID-19 Diagnosis. Front Immunol 2021;12:733171. [PMID: 34880855 DOI: 10.3389/fimmu.2021.733171] [Reference Citation Analysis]